The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone.
D002493:Central Nervous System Diseases / Q000139:chemically induced* / Q000517:prevention & control; D003907:Dexamethasone / Q000627:therapeutic use*; D004347:Drug Interactions; D006207:Half-Life; D006801:Humans; D008920:Misonidazole / Q000009:adverse effects* / Q000378:metabolism; D009593:Nitroimidazoles / Q000009:adverse effects*; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced* / Q000517:prevention & control; D010672:Phenytoin / Q000627:therapeutic use*
D009593:Nitroimidazoles; D010672:Phenytoin; D003907:Dexamethasone; D008920:Misonidazole